Metraipolis › archive › dc_bd4ae0fc328b

Burosumab treatment in an adult with FGF23-mediated hypophosphatemia due to cutaneous skeletal hypophosphatemia syndrome — Europe PMC PMID:41907689

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41907689
DOI
10.1210/jendso/bvag040
License (as archived)
solo-consultazione
Archived
2026-11-03T19:22:53.436Z
SHA-256 of the archived text
37a232d3da8bd4f15bc21bfa45b963e923fa3208652ce150dec99a5c120b013e
Stable URL of this page
https://metraipolis.com/documento/dc_bd4ae0fc328b

How to cite

Burosumab treatment in an adult with FGF23-mediated hypophosphatemia due to cutaneous skeletal hypophosphatemia syndrome — Europe PMC PMID:41907689 — Europe PMC (en), https://europepmc.org/article/MED/41907689 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd4ae0fc328b (Metraipolis archive dc_bd4ae0fc328b, sha256 37a232d3da8bd4f15bc21bfa45b963e923fa3208652ce150dec99a5c120b013e)
BibTeX
@misc{dcbd4ae0fc328b,
  title = {Burosumab treatment in an adult with FGF23-mediated hypophosphatemia due to cutaneous skeletal hypophosphatemia syndrome — Europe PMC PMID:41907689},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41907689},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd4ae0fc328b; sha256 37a232d3da8bd4f15bc21bfa45b963e923fa3208652ce150dec99a5c120b013e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907689. Agents can read the archived copy with the MCP tool read_document.